C. M. Hackeng

1.5k total citations
28 papers, 876 citations indexed

About

C. M. Hackeng is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, C. M. Hackeng has authored 28 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 7 papers in Internal Medicine. Recurrent topics in C. M. Hackeng's work include Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Coronary Interventions and Diagnostics (8 papers) and Atrial Fibrillation Management and Outcomes (8 papers). C. M. Hackeng is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (24 papers), Coronary Interventions and Diagnostics (8 papers) and Atrial Fibrillation Management and Outcomes (8 papers). C. M. Hackeng collaborates with scholars based in Netherlands, United States and Austria. C. M. Hackeng's co-authors include Jochem W. van Werkum, Heleen Bouman, Jurriën M. ten Berg, Nicoline J. Breet, Ankie M. Harmsze, Johannes C. Kelder, Ingrid A.M. Relou, J W N Akkerman, Hugo Ten Cate and Vera H.M. Deneer and has published in prestigious journals such as European Heart Journal, Cellular and Molecular Life Sciences and American Heart Journal.

In The Last Decade

C. M. Hackeng

27 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. M. Hackeng Netherlands 15 702 352 199 155 136 28 876
Elisabetta Ferrante United States 13 495 0.7× 224 0.6× 158 0.8× 130 0.8× 143 1.1× 19 790
Sasidhar Guthikonda United States 12 819 1.2× 370 1.1× 324 1.6× 128 0.8× 163 1.2× 15 1.1k
Chantal Pharand Canada 15 831 1.2× 345 1.0× 229 1.2× 119 0.8× 201 1.5× 40 1.0k
Geneviève Le Calvez France 8 604 0.9× 271 0.8× 125 0.6× 105 0.7× 155 1.1× 14 905
Laurent Macchi France 12 438 0.6× 205 0.6× 183 0.9× 63 0.4× 195 1.4× 30 682
Steen Dalby Kristensen Denmark 14 890 1.3× 352 1.0× 313 1.6× 85 0.5× 91 0.7× 21 1.3k
Nicolas Vignolles France 11 557 0.8× 293 0.8× 150 0.8× 143 0.9× 53 0.4× 13 744
Emilio Poggio United States 7 597 0.9× 278 0.8× 212 1.1× 74 0.5× 264 1.9× 10 905
Anne Bellemain-Appaix France 18 1.2k 1.7× 629 1.8× 276 1.4× 173 1.1× 137 1.0× 33 1.5k
Timothy DeLao United States 10 930 1.3× 339 1.0× 400 2.0× 119 0.8× 193 1.4× 10 1.1k

Countries citing papers authored by C. M. Hackeng

Since Specialization
Citations

This map shows the geographic impact of C. M. Hackeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. M. Hackeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. M. Hackeng more than expected).

Fields of papers citing papers by C. M. Hackeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. M. Hackeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. M. Hackeng. The network helps show where C. M. Hackeng may publish in the future.

Co-authorship network of co-authors of C. M. Hackeng

This figure shows the co-authorship network connecting the top 25 collaborators of C. M. Hackeng. A scholar is included among the top collaborators of C. M. Hackeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. M. Hackeng. C. M. Hackeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
6.
Bosma, Madeleen, Frans G. Waanders, Douwe van Loon, et al.. (2019). Automated and cost-efficient early detection of hemolysis in patients with extracorporeal life support: Use of the hemolysis-index of routine clinical chemistry platforms. Journal of Critical Care. 51. 29–33. 6 indexed citations
7.
Janssen, Paul W.A., Thomas O. Bergmeijer, Thea C. Godschalk, et al.. (2017). The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions. Journal of Thrombosis and Haemostasis. 15(4). 618–623. 14 indexed citations
8.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2011). High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention. Heart. 97(12). 983–990. 60 indexed citations
9.
Bouman, Heleen, Jochem W. van Werkum, Nicoline J. Breet, et al.. (2011). A case–control study on platelet reactivity in patients with coronary stent thrombosis. Journal of Thrombosis and Haemostasis. 9(5). 909–916. 18 indexed citations
10.
Harmsze, Ankie M., Jochem W. van Werkum, Patrick C. Souverein, et al.. (2011). Combined influence of proton‐pump inhibitors, calcium‐channel blockers and CYP2C19*2 on on‐treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. Journal of Thrombosis and Haemostasis. 9(10). 1892–1901. 37 indexed citations
11.
Breet, Nicoline J., Maayke A. Sluman, Jochem W. van Werkum, et al.. (2011). Effect of gender difference on platelet reactivity. Netherlands Heart Journal. 19(11). 451–457. 66 indexed citations
12.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2011). Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?. Netherlands Heart Journal. 19(6). 279–284. 19 indexed citations
13.
Harmsze, Ankie M., Jochem W. van Werkum, Jurriën M. ten Berg, et al.. (2010). CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. European Heart Journal. 31(24). 3046–3053. 117 indexed citations
14.
Breet, Nicoline J., Jochem W. van Werkum, Heleen Bouman, et al.. (2010). High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events. Journal of Thrombosis and Haemostasis. 8(10). 2140–2148. 67 indexed citations
15.
Bouman, Heleen, et al.. (2009). Cangrelor increases the magnitude of platelet inhibition and reduces interindividual variability in clopidogrel-pretreated subjects. Netherlands Heart Journal. 17(5). 195–198. 13 indexed citations
16.
Bouman, Heleen, Jochem W. van Werkum, Nicoline J. Breet, et al.. (2009). Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel. Journal of Thrombosis and Haemostasis. 8(3). 482–488. 87 indexed citations
17.
Werkum, Jochem W. van, Wim B. Gerritsen, Johannes C. Kelder, et al.. (2007). Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial. Netherlands Heart Journal. 15(11). 375–381. 13 indexed citations
18.
Hackeng, C. M., Marc M.H. Hermans, P.H.M. van der Kuy, et al.. (2004). The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. Journal of Nephrology. 17(1). 107–111. 16 indexed citations
19.
Relou, Ingrid A.M., C. M. Hackeng, J W N Akkerman, & Ernst Malle. (2003). Low-density lipoprotein and its effect on human blood platelets. Cellular and Molecular Life Sciences. 60(5). 961–971. 71 indexed citations
20.
Verhoeven, Nanda M., C. M. Hackeng, F.R. Leus, et al.. (1994). Apolipoprotein(a) isoform size influences binding of lipoprotein(a) to plasmin-modified des-AA-fibrinogen. Fibrinolysis and Proteolysis. 8(4). 214–220. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Ferrante Breakdown of academic impact, for papers by Sasidhar Guthikonda Breakdown of academic impact, for papers by Chantal Pharand Breakdown of academic impact, for papers by Geneviève Le Calvez Breakdown of academic impact, for papers by Laurent Macchi Breakdown of academic impact, for papers by Steen Dalby Kristensen Breakdown of academic impact, for papers by Nicolas Vignolles Breakdown of academic impact, for papers by Emilio Poggio Breakdown of academic impact, for papers by Anne Bellemain-Appaix Breakdown of academic impact, for papers by Timothy DeLao
Rankless by CCL
2026